Drug Discovery - Navigating CMC in Early Drug Development
View as a Web Page
News Medical
 
  Drug Discovery Drug Discovery logo  
  The latest drug discovery news from News Medical  
 

Smart Environmental Rooms Are Shaping the Future of TestingSmart Environmental Rooms Are Shaping the Future of Testing

As industries demand more precision, efficiency, and connectivity in environmental testing, smart technology redefines what’s possible. From remote monitoring to real-time data integration, the next generation of environmental rooms offers advanced control systems, energy savings, and seamless system integration. Discover how these innovations are helping labs and manufacturers meet evolving standards, optimize operations, and support sustainability goals.

Read the Article
 
 
    Navigating CMC in Early Drug DevelopmentNavigating CMC in Early Drug Development
 
Emerging sponsors often face resource constraints and tight timelines. This article outlines essential CMC strategies to avoid costly delays, strengthen regulatory submissions, and prepare for audits. Whether you're pre-IND or nearing Phase 2, don’t miss this practical guide to building a phase-appropriate CMC foundation.
 
Download the Whitepaper
 
 
   ColdBrew Enhances Accuracy of Protein Water Mapping for Drug DesignColdBrew Enhances Accuracy of Protein Water Mapping for Drug Design
 
Every protein in the body is encased in a water shell that directs protein structure, provides vital stability and steers function.
 
   Neem - Evidence-Based Health BenefitsNeem - Evidence-Based Health Benefits
 
Neem (Azadirachta indica) is a traditional medicinal plant now widely studied for its antimicrobial, antiviral, immunomodulatory, and metabolic effects. Contemporary research supports neem’s use in infection control, chronic disease management, dermatology, and oral health, while highlighting the need for standardization and clinical trials.
 
   Optibrium partners with TalTech on EU-funded PhD program to advance sustainable drug discoveryOptibrium partners with TalTech on EU-funded PhD program to advance sustainable drug discovery
 
Optibrium, a leading developer of software and AI solutions for molecular design, today announced its partnership with TalTech (Tallinn University of Technology) to co-supervise an EU-funded PhD position as part of the INNOCHEMBIO programme.
 
   Australian scientists use AI to create protein that kills superbugsAustralian scientists use AI to create protein that kills superbugs
 
In the last year, there has been a surge in proteins developed by AI that will eventually be used in the treatment of everything from snakebites to cancer. What would normally take decades for a scientist to create – a custom-made protein for a particular disease – can now be done in seconds.
 
 

How would you rate today's newsletter?

 
             
 
Facebook X Instagram LinkedIn Vimeo
Why did you receive this email?
You are receiving this email because you subscribed to updates from AZoNetwork UK Ltd. on one of our websites and requested to be notified of additional information.

Unsubscribe or Update Notification Preferences

Contact | About | Privacy Policy

- - - - - -

Registered Address:
AZoNetwork UK Ltd., NEO, 9 Charlotte St, Manchester, M1 4ET, UK

Manchester | Sydney | Boston

Copyright © 2000-2025